Inclusion of CA-125 Does Not Improve Mathematical Models Developed to Distinguish Between Benign and Malignant Adnexal Tumors
Authors:
- Dirk TimmermanDTDirk Timmerman
- Ben Van CalsterBCBen Van Calster
- Davor JurkovicDJDavor Jurkovic
- Lil ValentinLVLil Valentin
- Antonia C. TestaATAntonia C. Testa
- Jean-Pierre BernardJBJean-Pierre Bernard
- Caroline Van HolsbekeCHCaroline Van Holsbeke
- Sabine Van HuffelSHSabine Van Huffel
- Ignace VergoteIVIgnace Vergote
- Tom BourneTBTom Bourne
- 20 September 2007
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 25 (27) , 4194-4200
Abstract
Purpose: To test the value of serum CA-125 measurements alone or as part of a multimodal strategy to distinguish between malignant and benign ovarian tumors before surgery based on a large prospective multicenter study (International Ovarian Tumor Analysis). Patients and Methods: Patients with at least one persistent ovarian mass preoperatively underwent transvaginal ultrasonography using gray scale imaging to assess tumor morphology and color Doppler imaging to obtain indices of blood flow. Results: Data from 809 patients recruited from nine centers were included in the analysis; 567 patients (70%) had benign tumors and 242 (30%) had malignant tumors—of these 152 were primary invasive (62.8%), 52 were borderline malignant (21.5%), and 38 were metastatic (15.7%). A logistic regression model including CA-125 (M2) resulted in an area under the receiver operating characteristic curve (AUC) of 0.934 and did not outperform a published (M1) without serum CA-125 information (AUC, 0.936). Specifically designed new models including CA-125 for premenopausal women (M3) and for postmenopausal women (M4) did not perform significantly better than the model without CA-125 (M1; AUC, 0.891 v AUC, 0.911 and AUC, 0.975 v AUC, 0.949, respectively). In postmenopausal patients, serum CA-125 alone (AUC, 0.920) and the risk of malignancy index (AUC, 0.924) performed very well. Results were very similar when the models were prospectively tested on a group of 345 new patients with adnexal masses of whom 126 had malignant tumors (37%). Conclusion: Adding information on CA-125 to clinical information and ultrasound information does not improve discrimination of mathematical models between benign and malignant adnexal masses.Keywords
This publication has 32 references indexed in Scilit:
- Laparoscopy in patients over 60 years old: A prospective, randomized evaluation of laparoscopic versus open adnexectomyAmerican Journal of Obstetrics and Gynecology, 2005
- Laparoscopy versus laparotomy for benign ovarian tumour2005
- Laparoscopy versus Laparotomy in the Management of Benign Unilateral Adnexal MassesThe Journal of the American Association of Gynecologic Laparoscopists, 2002
- Artificial neural network models for the preoperative discrimination between malignant and benign adnexal massesUltrasound in Obstetrics & Gynecology, 1999
- Transvaginal ultrasonographic characterization of ovarian masses: comparison of five scoring systems in a multicenter studyUltrasound in Obstetrics & Gynecology, 1997
- Transvaginal ultrasonographic characterization of ovarian masses with an improved, weighted scoring systemAmerican Journal of Obstetrics and Gynecology, 1994
- A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancerBJOG: An International Journal of Obstetrics & Gynaecology, 1990
- Macroscopic characterization of ovarian tumors and the relation to the histological diagnosis: Criteria to be used for ultrasound evaluationGynecologic Oncology, 1989
- Prognostic factors in advanced ovarian carcinoma.Journal of Clinical Oncology, 1986
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983